We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.79B
AUM Growth
-$19.8M
Cap. Flow
-$506M
Cap. Flow %
-7.46%
Top 10 Hldgs %
64.12%
Holding
139
New
17
Increased
28
Reduced
77
Closed
11

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$17M
2
JNJ icon
Johnson & Johnson
JNJ
+$12.1M
3
SHPG
Shire pic
SHPG
+$8.78M
4
AGN
Allergan plc
AGN
+$5.04M
5
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$2.88M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$41.2M
2
HDB icon
HDFC Bank
HDB
+$38.7M
3
UNP icon
Union Pacific
UNP
+$29.7M
4
MSFT icon
Microsoft
MSFT
+$28.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 34.47%
2 Healthcare 19.26%
3 Communication Services 16.08%
4 Consumer Discretionary 11.63%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$21.4M 0.31%
394,254
-160,552
-29% -$8.95M
SLXP
27
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$21.2M 0.31%
184,025
+140,125
+319% +$17M
VTRS icon
28
Viatris
VTRS
$20.7B
$19.6M 0.29%
346,999
-40,322
-10% -$2.17M
BHC icon
29
Bausch Health
BHC
$1.68B
$19.3M 0.28%
134,961
-35,420
-21% -$4.76M
HCA icon
30
HCA Healthcare
HCA
$92B
$17.8M 0.26%
242,975
-23,204
-9% -$1.63M
SHPG
31
DELISTED
Shire pic
SHPG
$17.7M 0.26%
83,509
+41,400
+98% +$8.78M
CTRX
32
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$17.3M 0.25%
333,456
-101,234
-23% -$4.76M
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
$17.2M 0.25%
203,401
-46,843
-19% -$3.66M
COR icon
34
Cencora
COR
$62.1B
$16.9M 0.25%
186,900
-17,249
-8% -$1.48M
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$16.1B
$16.2M 0.24%
98,954
-57,324
-37% -$9.51M
MDVN
36
DELISTED
MEDIVATION, INC.
MDVN
$13.9M 0.2%
278,364
-152,154
-35% -$7.91M
CNC icon
37
Centene
CNC
$30.8B
$12.9M 0.19%
498,800
-92,548
-16% -$2.16M
AGN
38
DELISTED
Allergan Inc
AGN
$12.2M 0.18%
57,460
-6,598
-10% -$1.31M
KERX
39
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$11.4M 0.17%
805,502
-434,304
-35% -$6.73M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.9B
$10.4M 0.15%
114,685
-19,633
-15% -$1.63M
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
$8.63M 0.13%
46,661
-38,969
-46% -$7.22M
ZBH icon
42
Zimmer Biomet
ZBH
$18.6B
$8.1M 0.12%
73,584
-76,522
-51% -$8.07M
CERN
43
DELISTED
Cerner Corp
CERN
$7.82M 0.12%
120,978
-80,781
-40% -$5.03M
IONS icon
44
Ionis Pharmaceuticals
IONS
$9.03B
$7.79M 0.11%
126,180
-61,320
-33% -$3.03M
DVA icon
45
DaVita
DVA
$15.5B
$7.46M 0.11%
98,491
-11,309
-10% -$851K
AIRM
46
DELISTED
Air Methods Corp
AIRM
$7.27M 0.11%
165,151
-76,398
-32% -$3.58M
DHR icon
47
Danaher
DHR
$140B
$6.59M 0.1%
114,483
-13,145
-10% -$713K
NKE icon
48
Nike
NKE
$63.2B
$5.99M 0.09%
124,680
+2,000
+2% +$93.8K
CEMP
49
DELISTED
Cempra, Inc.
CEMP
$5.56M 0.08%
236,584
-81,416
-26% -$1.22M
ASPX
50
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$5.14M 0.08%
+97,921
New +$2.88M
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2014 Portfolio in Review

As of Q4 2014, C WorldWide Group held 139 positions worth $6.79B, down 0.29% from $6.81B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

C WorldWide Group withdrew a net $506M in Q4 2014, closing 11 positions and reducing 77 holdings. Its most notable exit was AUXILIUM PHARAMCEUTICALS INC, an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in AUSPEX PHARMACEUTICALS INC COM STK (DE) worth $5.14M.

  • C WorldWide Group's largest Q4 2014 buy was AUSPEX PHARMACEUTICALS INC COM STK (DE): 97,921 shares worth $5.14M.
  • C WorldWide Group added most to SALIX PHARMACEUTICALS LTD DEL in Q4 2014, an estimated $17M increase.
  • C WorldWide Group's biggest Q4 2014 reduction was Visa, cutting an estimated $41.2M.
  • C WorldWide Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $8.32M.
  • C WorldWide Group's ten largest holdings make up 64% of its $6.79B portfolio in Q4 2014.
  • C WorldWide Group opened 17 new positions and closed 11 in Q4 2014.
  • C WorldWide Group's portfolio value fell 0.29% quarter-over-quarter to $6.79B.

Based on C WorldWide Group's 13F filing for Q4 2014, filed 11 Feb 2015.